Selected article for: "immune response and response modulate"
Author: Romero, Alejandro; Ramos, Eva; López-Muñoz, Francisco; Gil-Martín, Emilio; Escames, Germaine; Reiter, Russel J.
Title: Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
  • Cord-id: 4ifwiisy
  • Document date: 2020_8_9
    • ID: 4ifwiisy
    Snippet: The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the clinical symptoms mostly have been characterized, the scientific community still doesn´t know how SARS-CoV-2 successfully reaches and spreads throughout the central nervous system (CNS) inducing brain damage. The recent detection of SARS-CoV-2 in the ce
    Document: The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the clinical symptoms mostly have been characterized, the scientific community still doesn´t know how SARS-CoV-2 successfully reaches and spreads throughout the central nervous system (CNS) inducing brain damage. The recent detection of SARS-CoV-2 in the cerebrospinal fluid (CSF) and in frontal lobe sections from postmortem examination has confirmed the presence of the virus in neural tissue. This finding reveals a new direction in the search for a neurotherapeutic strategy in the COVID-19 patients with underlying diseases. Here, we discuss the COVID-19 outbreak in a neuroinvasiveness context and suggest the therapeutic use of high doses of melatonin, which may favorably modulate the immune response and neuroinflammation caused by SARS-CoV-2. However, clinical trials elucidating the efficacy of melatonin in the prevention and clinical management in the COVID-19 patients should be actively encouraged.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and administration impact: 1, 2, 3
    • acute ards respiratory distress syndrome and administration route: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and long term short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and long term short study: 1
    • acute ards respiratory distress syndrome and low concentration: 1
    • acute ards respiratory distress syndrome and low medium: 1, 2, 3
    • acute ards respiratory distress syndrome and low medium dose: 1
    • acute ards respiratory distress syndrome and low prevalence: 1, 2
    • acute ards respiratory distress syndrome and low toxicity: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung burden: 1
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
    • acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and magnetic resonance imaging: 1, 2, 3, 4, 5, 6
    • acute cerebrovascular disease and long term consequence: 1
    • acute cerebrovascular disease and magnetic resonance: 1, 2, 3
    • acute cerebrovascular disease and magnetic resonance imaging: 1, 2, 3
    • acute patient respiratory failure and long term short: 1
    • acute patient respiratory failure and magnetic resonance: 1
    • acute patient respiratory failure and magnetic resonance imaging: 1